Scholars Central

Conference abstract

Integrin targeted RNAi and macromolecule therapeutics for treatment of cancers and invasive fungal infections

Authors: Martin C Woodle

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Efforts to develop tissue-targeted therapeutics have made clinical advances through antibody conjugates and nanoparticles, with primary successful clinical applications for treatment of cancers. Advances are based on a growing understanding that systemic targeted therapy depends upon reduction of non-specific interactions, most commonly accomplished with nanoparticles by PEGylation. A large number of preclinical studies suggest that ligand-targeted nanoparticles can permit tissue-specific intracellular delivery of RNAi or gene therapy agents. A portfolio of therapeutics that utilize integrin targeting to neovasculature, associated with a wide range of tumor types as well as sites of infection is developed. A portfolio of integrin targeted nanoparticle therapeutics is being developed for treatment of cancers that utilize RNAi and gene therapy agents that have a potential for multiple mechanisms of action, and are expected to be complementary with existing chemotherapy and targeted therapy inhibitors of proteins. A line of integrin targeted therapeutics is being developed for treatment of life threatening invasive fungal infections that utilize a novel branched histidine rich polyamide macromolecule class of antimicrobials. The development of these integrin targeted therapeutics will be described along with consideration of challenges to successful clinical translation.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Stem Cell Research & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Stem Cell Research & Therapy
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Martin C Woodle”